2nd Annual Nanomedicine: Commercializing Drug Delivery, Diagnostics, and Medical Devices

Venue: Hyatt Regency Crystal City

Location: Arlington, Virginia, United States

Event Date/Time: Mar 26, 2007 End Date/Time: Mar 27, 2007
Report as Spam


Nanotech researchers, executives, policy-makers, patent practitioners, and investors from the medical, business, patent and life sciences community will gather in Arlington, VA in March for the 2nd Annual Nanomedicine Conference to discuss the most important applications of nanotechnology in drug delivery, diagnostics and medical devices. Last year’s conference was so successful that a lead cover story covering last year’s conference appeared in the Genetic Engineering News. What’s new for 2007? Cutting-edge R&D, commercialization strategies, regulatory and IP issues will be highlighted over the two days. Also, new applications in the medical device industry will be covered. The full two day conference will consist of presentations, panels and networking opportunities with representatives from industry, government and academia.


Novel targeted drug delivery and earlier diagnosis via various nanomaterial-based nanomedicines: Nanoparticles; Dendrimers; Nanoliposomes; Quantum dots; Carbon nanotubes; Fullerenes; etc.
Emerging role of nanotechnology based drug discovery, focusing on:
High throughput screening
Lab-on-a-chip devices
Single molecule analysis via DNA “barcode” and AFM arrays
Functional imaging using in vivo screening
Commercializing Nanomedicine: From the Lab to the Clinic
Assessing IP, licensing and nanobusiness opportunities and challenges
Health, environmental, policy and ethical issues
Role of federal agencies: Patent Office; FDA; NNCO; EPA; NASA; NIST
Fabricating novel nanodevices, including
Novel Materials
Micro/nano fluidics
Remote monitoring and delivery
The future role of pharmacogenomics and personalized medicine in nanomedicine